Home » Topics » Disease categories and therapies » Immune

Immune
RSS

KS Biomedix forms collaboration with Eukarion

Aug. 31, 2000

Viral protein products reduce transplant rejection in preclinical study

Aug. 30, 2000

Novartis updates transplantation pipeline at ongoing congress

Aug. 30, 2000

Tablet form of Rapamune receives FDA approval

Aug. 30, 2000

Active Biotech updates agreements for traveler's diarrhea vaccines

Aug. 28, 2000

Pteridine derivatives reported by K.U. Leuven as treatment for autoimmune disorders

Aug. 25, 2000

Naked DNA malaria vaccine phase II clinical trial commences

Aug. 25, 2000

Altea Genomics and Elan to jointly develop DNA vaccines

Aug. 24, 2000

Antex Biologics signs CRADA with U.S. Navy for Campylobacter vaccine

Aug. 24, 2000

cDNA clones of tick-borne flavivirus available for licensing from NIH

Aug. 22, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...